Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 4847812, 10 pages
http://dx.doi.org/10.1155/2016/4847812
Research Article

Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression

1Department of Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, China
2Department of Cardiology, Central Hospital of Minhang District, 170 Xinsong Road, Shanghai 201199, China

Received 30 May 2016; Accepted 22 August 2016

Academic Editor: Peter Thule

Copyright © 2016 Zhong’e Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Zeller and S. Srivastava, “Macrophage functions in atherosclerosis,” Circulation Research, vol. 115, no. 12, pp. e83–e85, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Ley, Y. I. Miller, and C. C. Hedrick, “Monocyte and macrophage dynamics during atherogenesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 7, pp. 1506–1516, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Peled and E. A. Fisher, “Dynamic aspects of macrophage polarization during atherosclerosis progression and regression,” Frontiers in Immunology, vol. 5, article 579, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. G. P. Fadini, R. Cappellari, M. Mazzucato, C. Agostini, S. Vigili De Kreutzenberg, and A. Avogaro, “Monocyte-macrophage polarization balance in pre-diabetic individuals,” Acta Diabetologica, vol. 50, no. 6, pp. 977–982, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. G. P. Fadini, S. V. De Kreutzenberg, E. Boscaro et al., “An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy,” Diabetologia, vol. 56, no. 8, pp. 1856–1866, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Jin, L. Liu, Z. Zhou, J. Ge, T. Yao, and C. Shen, “Pioglitazone alleviates inflammation in diabetic mice fed a high-fat diet via inhibiting advanced glycation end-product-induced classical macrophage activation,” The FEBS Journal, vol. 283, no. 12, pp. 2295–2308, 2016. View at Publisher · View at Google Scholar
  7. X. Jin, T. Yao, Z. Zhou et al., “Advanced glycation end products enhance macrophages polarization into M1 phenotype through activating RAGE/NF-B Pathway,” BioMed Research International, vol. 2015, Article ID 732450, 12 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Prasad, P. Bekker, and S. Tsimikas, “Advanced glycation end products and diabetic cardiovascular disease,” Cardiology in Review, vol. 20, no. 4, pp. 177–183, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Viollet, B. Guigas, N. Sanz Garcia, J. Leclerc, M. Foretz, and F. Andreelli, “Cellular and molecular mechanisms of metformin: an overview,” Clinical Science, vol. 122, no. 6, pp. 253–270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Mamputu, N. F. Wiernsperger, and G. Renier, “Antiatherogenic properties of metformin: the experimental evidence,” Diabetes and Metabolism, vol. 29, no. 4, pp. 6–13, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Kim, H. J. Kwak, J.-Y. Cha et al., “Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via Activating Transcription Factor-3 (ATF-3) induction,” The Journal of Biological Chemistry, vol. 289, no. 33, pp. 23246–23255, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. Ł. Bułdak, K. Łabuzek, R. J. Bułdak et al., “Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macrophages,” Pharmacological Reports, vol. 66, no. 3, pp. 418–429, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Ishibashi, T. Matsui, M. Takeuchi, and S. Yamagishi, “Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression,” Hormone and Metabolic Research, vol. 44, no. 12, pp. 891–895, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Gu, S. Ye, S. Wang, W. Sun, and Y. Hu, “Metformin inhibits nuclear factor-κB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vitro,” Chinese Medical Journal, vol. 127, no. 9, pp. 1755–1760, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Hattori, K. Suzuki, S. Hattori, and K. Kasai, “Metformin inhibits cytokine-induced nuclear factor κB activation via AMP-activated protein kinase activation in vascular endothelial cells,” Hypertension, vol. 47, no. 6, pp. 1183–1188, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. A. Kim and H. C. Choi, “Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells,” Biochemical and Biophysical Research Communications, vol. 425, no. 4, pp. 866–872, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Wan, Y. Huo, M. Johns et al., “5'-AMP-activated protein kinase-activating transcription factor 1 cascade modulates human monocyte-derived macrophages to atheroprotective functions in response to heme or metformin,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 11, pp. 2470–2480, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Chinetti-Gbaguidi, S. Colin, and B. Staels, “Macrophage subsets in atherosclerosis,” Nature Reviews Cardiology, vol. 12, no. 1, pp. 10–17, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. A. C. Labonte, A.-C. Tosello-Trampont, and Y. S. Hahn, “The role of macrophage polarization in infectious and inflammatory diseases,” Molecules and Cells, vol. 37, no. 4, pp. 275–285, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. Q. Qin, J. Niu, Z. Wang, W. Xu, Z. Qiao, and Y. Gu, “Astragalus membranaceus inhibits inflammation via phospho-p38 mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-κB pathways in advanced glycation end product-stimulated macrophages,” International Journal of Molecular Sciences, vol. 13, no. 7, pp. 8379–8387, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Miyata, R. Inagi, Y. Iida et al., “Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1,” The Journal of Clinical Investigation, vol. 93, no. 2, pp. 521–528, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Hattori, K. Hattori, and T. Hayashi, “Pleiotropic benefits of metformin: macrophage targeting its anti-inflammatory mechanisms,” Diabetes, vol. 64, no. 6, pp. 1907–1909, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. S. B. Vasamsetti, S. Karnewar, A. K. Kanugula, A. R. Thatipalli, J. M. Kumar, and S. Kotamraju, “Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis,” Diabetes, vol. 64, no. 6, pp. 2028–2041, 2015. View at Publisher · View at Google Scholar
  24. C. Ott, K. Jacobs, E. Haucke, A. Navarrete Santos, T. Grune, and A. Simm, “Role of advanced glycation end products in cellular signaling,” Redox Biology, vol. 2, no. 1, pp. 411–429, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Cheng, Y. Dong, F. Zhu, Y. Liu, F. F. Hou, and J. Nie, “AGE-LDL activates toll like receptor 4 pathway and promotes inflammatory cytokines production in renal tubular epithelial cells,” International Journal of Biological Sciences, vol. 9, no. 1, pp. 94–107, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Neacsu, A. Mazare, P. Schmuki, and A. Cimpean, “Attenuation of the macrophage inflammatory activity by TiO2 nanotubes via inhibition of MAPK and NF-κB pathways,” International Journal of Nanomedicine, vol. 10, pp. 6455–6467, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Hu, J. Chen, L. Wang, and L. B. Ivashkiv, “Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation,” Journal of Leukocyte Biology, vol. 82, no. 2, pp. 237–243, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Salminen, J. M. T. Hyttinen, and K. Kaarniranta, “AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan,” Journal of Molecular Medicine, vol. 89, no. 7, pp. 667–676, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. B.-P. Huang, C.-H. Lin, H.-M. Chen, J.-T. Lin, Y.-F. Cheng, and S.-H. Kao, “AMPK activation inhibits expression of proinflammatory mediators through downregulation of PI3K/p38 MAPK and NF-κB signaling in murine macrophages,” DNA and Cell Biology, vol. 34, no. 2, pp. 133–141, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Chen, J. Zhang, F. Hu, S. Liu, and Z. Zhou, “Metformin affects the features of a human hepatocellular cell line (HepG2) by regulating macrophage polarization in a co-culture microenviroment,” Diabetes/Metabolism Research and Reviews, vol. 31, no. 8, pp. 781–789, 2016. View at Publisher · View at Google Scholar · View at Scopus